ADVERTISEMENT
Man in blue shirt and tie looking at camera.
Pharmacologist and Olympian David Bailey Dies at 77
He was best known for his discovery that grapefruit juice makes some medications less effective or potentially dangerous.
Pharmacologist and Olympian David Bailey Dies at 77
Pharmacologist and Olympian David Bailey Dies at 77

He was best known for his discovery that grapefruit juice makes some medications less effective or potentially dangerous.

He was best known for his discovery that grapefruit juice makes some medications less effective or potentially dangerous.

pharmacology
pharmacology medicine parkinson's disease dopamine l-dopa levodopa Hornykiewicz obituary
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Amanda Heidt | Jun 18, 2020 | 3 min read
The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020 | 3 min read
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
Building a Synthetic Biology Platform for Drug Delivery
Building a Synthetic Biology Platform for Drug Delivery
The Scientist Creative Services Team | 1 min read
Kate Adamala and Niren Murthy will discuss the latest advances in drug delivery using synthetic biology approaches.
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Amy Schleunes | Apr 7, 2020 | 2 min read
Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.
mdma ecstacy serotonin dopamine
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Ruth Williams | Dec 11, 2019 | 3 min read
A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.
One Size Does Not Fit All: Pharmacogenomics in Precision Medicine
The Scientist Creative Services Team | 1 min read
Sandosh Padmanabhan and Andrew Morrow will discuss how pharmacogenomics methods improve precision medicine for cardiovascular disease treatment.
an illustration of dividing cancer cells
Cancer Drugs in Development May Be Targeting Wrong Proteins
Shawna Williams | Sep 12, 2019 | 3 min read
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Hydrogel injected near tumors help recruit cancer drugs to the site
Image of the Day: Right on Target
Nicoletta Lanese | Jul 23, 2019 | 1 min read
An injectable biomaterial calls cancer drugs to tumor sites in mice.
Perfecting Dose Response Assays
The Scientist Creative Services Team | 1 min read
Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019 | 3 min read
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
head shot of Anthony Fauci
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018 | 3 min read
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018 | 10+ min read
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018 | 3 min read
Researchers use several different strategies to deliver a one-two punch.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
Jim Daley | Feb 7, 2018 | 3 min read
The Scientist speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.
Nasser Zawia: An American Scientist Born in Yemen
Bob Grant | Mar 23, 2017 | 4 min read
The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s. 
Mystery Mechanisms
Tanya Lewis | Jul 29, 2016 | 3 min read
Scientists still don’t know exactly how some commonly used drugs work. Here’s a look at three such compounds.
Antibiotic Assistants
Ruth Williams | Mar 9, 2016 | 3 min read
Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.  
Hearing Help
Kate Yandell | Sep 1, 2015 | 10+ min read
For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
 
Light-Operated Drugs
Ruth Williams | Nov 1, 2014 | 2 min read
Scientists create a photosensitive pharmaceutical to target a glutamate receptor.
ADVERTISEMENT